Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 77 record(s)

Req # A-2018-000944

All documents describing any and all features of the "class exemption" issued by the Minister of Health under s. 56 of the Controlled Drugs and Substances.

Organization: Health Canada

44 page(s)
July 2022

Req # A-2021-001353

All historical product labels for pesticides containing the chemical Paraquat from January 1, 1960 to November 29, 2021 in paper format at the time of this request.

Organization: Health Canada

210 page(s)
July 2022

Req # A-2022-000067

A list of the grants and other payments made by Health Canada to Physicians for A Smoke Free Canada from January 1, 2012 to December 31, 2021. Include the amount paid and when they were paid. A list of the documents or services or other work products Health Canada has received in exchange for these grants and other payments for the same time period (January 1, 2012 to December 31, 2021).

Organization: Health Canada

10 page(s)
July 2022

Req # A-2022-000155

Footnote #37 of the Evaluation of the Health Portfolio Tobacco and Vaping Activities 2016-17 to 2020-21, made public on Health Canada's website on April 26, 2022 makes reference to the following document: "Health Canada (2017). Technical Reference Sheet Harm Reduction & Cessation". A copy of this document/report.

Organization: Health Canada

6 page(s)
July 2022

Req # A-2021-001045

Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_03811824, E2B_03841105, E2B_03840754.

Organization: Health Canada

65 page(s)
July 2022

Req # A-2021-002112

Adverse Drug Reactions (ADRs) for METRONIDAZOLE, METFORMIN HYDROCHLORIDE. Report numbers: E2B_04948923, E2B_04707501.

Organization: Health Canada

35 page(s)
July 2022

Req # A-2021-002151

Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_04749239.

Organization: Health Canada

52 page(s)
July 2022

Req # A-2022-000044

Adverse Drug Reaction (ADR) for Zostavax II. Report number: E2B_02235603.

Organization: Health Canada

32 page(s)
July 2022

Req # A-2022-000076

Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE. Report number: E2B_05082566.

Organization: Health Canada

23 page(s)
July 2022

Req # A-2022-000080

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_02647003, E2B_02646771.

Organization: Health Canada

31 page(s)
July 2022
Date modified: